Identifying MS gene mutations could lead to personalised....

[MSUK]

Identifying MS gene mutations could lead to personalised treatments

Personalised medicine, often applied to treat cancer, may be possible for patients with multiple sclerosis as well. Certain patients respond differently to certain multiple sclerosis medications, such as interferon-β (IFNβ), and researchers at San Raffaele Scientific Institute in Milan may have an answer as to why.... Read More - http://www.ms-uk.org/genetics